or Try an Advanced Search...

    Technical Analysis for LTRN - Lantern Pharma Inc.

    Grade Last Price % Change Price Change
    B 5.34 -7.45% -0.43
    LTRN closed down 7.45 percent on Friday, April 19, 2024, on 62 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical LTRN trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -7.45%
    Narrow Range Bar Range Contraction -7.45%
    Inside Day Range Contraction -7.45%
    Wide Bands Range Expansion -7.45%
    Oversold Stochastic Weakness -7.45%
    Lower Bollinger Band Walk Weakness -10.85%
    Older End-of-Day Signals for LTRN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 16 hours ago
    Down 5% about 16 hours ago
    Down 3% about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    Down 2 % about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    LTRN Chart by TradingView
    Basic chart:

    Profile

    Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Artificial Intelligence Machine Learning Cybernetics Computational Neuroscience Pharma

    Is LTRN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 19 Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript
    Mar 19 LTRN: 2023 Results
    Mar 19 Lantern Pharma Inc. (LTRN) Q4 2023 Earnings Call Transcript
    Mar 18 Lantern Pharma Inc Reports Progress and Financials for FY 2023
    Mar 18 Lantern Pharma GAAP EPS of -$0.39 beats by $0.01
    Mar 18 Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
    Mar 18 Earnings Scheduled For March 18, 2024
    Mar 15 Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
    Mar 11 Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
    Mar 7 11 Best Artificial Intelligence Stocks Under $20 According To Hedge Funds
    See more LTRN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.99
    52 Week Low 2.38
    Average Volume 381,441
    200-Day Moving Average 4.65
    50-Day Moving Average 6.52
    20-Day Moving Average 7.84
    10-Day Moving Average 6.54
    Average True Range 0.94
    RSI (14) 37.11
    ADX 27.6
    +DI 16.44
    -DI 27.88
    Chandelier Exit (Long, 3 ATRs) 9.16
    Chandelier Exit (Short, 3 ATRs) 8.03
    Upper Bollinger Bands 11.06
    Lower Bollinger Band 4.63
    Percent B (%b) 0.11
    BandWidth 81.88
    MACD Line -0.42
    MACD Signal Line 0.00
    MACD Histogram -0.4172
    Fundamentals Value
    Market Cap 57.26 Million
    Num Shares 10.7 Million
    EPS -1.39
    Price-to-Earnings (P/E) Ratio -3.84
    Price-to-Sales 0.00
    Price-to-Book 0.98
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.02
    Resistance 3 (R3) 6.04 5.85 5.90
    Resistance 2 (R2) 5.85 5.67 5.83 5.86
    Resistance 1 (R1) 5.59 5.57 5.50 5.57 5.83
    Pivot Point 5.40 5.40 5.35 5.38 5.40
    Support 1 (S1) 5.14 5.22 5.05 5.12 4.85
    Support 2 (S2) 4.95 5.12 4.93 4.82
    Support 3 (S3) 4.69 4.95 4.78
    Support 4 (S4) 4.67